{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:30:16Z","timestamp":1790188216845,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.neuint.2021.105070","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T11:03:39Z","timestamp":1621076619000},"page":"105070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells"],"prefix":"10.1016","volume":"147","author":[{"given":"Iqra","family":"Nazish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9743-8134","authenticated-orcid":false,"given":"Charles","family":"Arber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-3417","authenticated-orcid":false,"given":"Thomas M.","family":"Piers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-8815","authenticated-orcid":false,"given":"Rina","family":"Bandopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2021.105070_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fnins.2020.00193","article-title":"Leucine rich repeat kinase 2 and innate immunity","volume":"14","author":"Ahmadi Rastegar","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2021.105070_bib2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/mds.27601","article-title":"LRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients","volume":"34","author":"Atashrazm","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2021.105070_bib3","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/MCB.01331-13","article-title":"Rab8 binding to immune cell-specific adaptor LAX facilitates formation of trans-Golgi network-proximal CTLA-4 vesicles for surface expression","volume":"34","author":"Banton","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.neuint.2021.105070_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2021.105070_bib5","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50416","article-title":"PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins","volume":"8","author":"Berndsen","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.neuint.2021.105070_bib6","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/hmg\/dds522","article-title":"GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2","volume":"22","author":"Biosa","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105070_bib7","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1038\/ncomms6827","article-title":"Phosphorylation of LRRK2 by casein kinase 1alpha regulates trans-Golgi clustering via differential interaction with ARHGEF7","volume":"5","author":"Chia","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2021.105070_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","article-title":"LRRK2 levels in immune cells are increased in Parkinson's disease","volume":"3","author":"Cook","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.neuint.2021.105070_bib9","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1073\/pnas.1403215111","article-title":"Abrogation of alpha-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats","volume":"111","author":"Daher","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105070_bib10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3389\/fimmu.2019.01107","article-title":"Immune control by TRAF6-mediated pathways of epithelial cells in the EIME (epithelial immune microenvironment)","volume":"10","author":"Dainichi","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuint.2021.105070_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/1073858418756309","article-title":"LRRK2 phosphorylation: behind the scenes","volume":"24","author":"De Wit","year":"2018","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuint.2021.105070_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar5429","article-title":"LRRK2 activation in idiopathic Parkinson's disease","volume":"10","author":"Di Maio","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2021.105070_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1471-4159.2011.07537.x","article-title":"Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson's disease mutations and LRRK2 pharmacological inhibition","volume":"120","author":"Doggett","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2021.105070_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039132","article-title":"The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling","volume":"7","author":"Dzamko","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2021.105070_bib15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.26529","article-title":"Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers","volume":"31","author":"Dzamko","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2021.105070_bib16","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3389\/fnins.2019.01381","article-title":"Vesicular dysfunction and the pathogenesis of Parkinson's disease: clues from genetic studies","volume":"13","author":"Ebanks","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2021.105070_bib17","doi-asserted-by":"crossref","first-page":"E9115","DOI":"10.1073\/pnas.1812196115","article-title":"LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis","volume":"115","author":"Eguchi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105070_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/BCJ20170803","article-title":"Interrogating Parkinson's disease LRRK2 kinase pathway activity by assessing Rab10 phosphorylation in human neutrophils","volume":"475","author":"Fan","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2021.105070_bib19","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.celrep.2018.07.094","article-title":"Human induced pluripotent stem cell-derived microglia-like cells harboring TREM2 missense mutations show specific deficits in phagocytosis","volume":"24","author":"Garcia-Reitboeck","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuint.2021.105070_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","article-title":"Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity","volume":"208","author":"Gillardon","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2021.105070_bib21","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1093\/hmg\/ddu395","article-title":"LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity","volume":"23","author":"Gomez-Suaga","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105070_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105070_bib23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","article-title":"Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures","volume":"118","author":"Hakimi","year":"2011","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2021.105070_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/BST20180464","article-title":"The role of LRRK2 in cell signalling","volume":"47","author":"Harvey","year":"2019","journal-title":"Biochem. Soc. Trans."},{"issue":"Suppl. 3","key":"10.1016\/j.neuint.2021.105070_bib25","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1016\/S1353-8020(09)70815-6","article-title":"Clinical features of LRRK2 parkinsonism","volume":"15","author":"Haugarvoll","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuint.2021.105070_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2021.105070_bib27","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1091\/mbc.E16-02-0091","article-title":"Rabin8 regulates neurite outgrowth in both GEF activity-dependent and -independent manners","volume":"27","author":"Homma","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuint.2021.105070_bib28","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1042\/BCJ20160557","article-title":"Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors","volume":"473","author":"Ito","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2021.105070_bib29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuint.2021.105070_bib30","author":"Kim"},{"key":"10.1016\/j.neuint.2021.105070_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41531-018-0049-1","article-title":"Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity","volume":"4","author":"Kluss","year":"2018","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.neuint.2021.105070_bib32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/jnc.12668","article-title":"Interferon-gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5 in macrophages","volume":"129","author":"Kuss","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2021.105070_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.2199","article-title":"Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease","volume":"16","author":"Lee","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2021.105070_bib34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.stemcr.2020.04.001","article-title":"LRRK2 is recruited to phagosomes and Co-recruits RAB8 and RAB10 in human pluripotent stem cell-derived macrophages","volume":"14","author":"Lee","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuint.2021.105070_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/BST20160262","article-title":"LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease","volume":"45","author":"Lee","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuint.2021.105070_bib36","first-page":"470","article-title":"[LRRK2 is a major gene in North African parkinsonism]","volume":"22","author":"Lesage","year":"2006","journal-title":"Med. Sci."},{"key":"10.1016\/j.neuint.2021.105070_bib37","doi-asserted-by":"crossref","first-page":"26470","DOI":"10.1074\/jbc.M111.227934","article-title":"Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties","volume":"286","author":"Liang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105070_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19124074","article-title":"Roco proteins and the Parkinson's disease-associated LRRK2","volume":"19","author":"Liao","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuint.2021.105070_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BJ20121772","article-title":"Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle","volume":"456","author":"Lobbestael","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2021.105070_bib40","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddm151","article-title":"Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation","volume":"16","author":"Luzon-Toro","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105070_bib41","doi-asserted-by":"crossref","first-page":"21386","DOI":"10.1074\/jbc.M113.528463","article-title":"Arsenite stress down-regulates phosphorylation and 14-3-3 binding of leucine-rich repeat kinase 2 (LRRK2), promoting self-association and cellular redistribution","volume":"289","author":"Mamais","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105070_bib42","article-title":"Pathogenic mutations in LRRK2 sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia","author":"Mamais","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuint.2021.105070_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2013.05.017","article-title":"Divergent alpha-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases","volume":"58","author":"Mamais","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105070_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2021.105070_bib45","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1194\/jlr.M040212","article-title":"Analysis of inflammatory and lipid metabolic networks across RAW264.7 and thioglycolate-elicited macrophages","volume":"54","author":"Maurya","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.neuint.2021.105070_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2005.01.003","article-title":"The RIP kinases: crucial integrators of cellular stress","volume":"30","author":"Meylan","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuint.2021.105070_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-49969-7_4","article-title":"Understanding the GTPase activity of LRRK2: regulation, function, and neurotoxicity","volume":"14","author":"Nguyen","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.neuint.2021.105070_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20100483","article-title":"14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization","volume":"430","author":"Nichols","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2021.105070_bib49","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2021.105070_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/cells9081878","article-title":"The Michael J. Fox foundation's strategies for accelerating translation of LRRK2 into therapies for Parkinson disease","volume":"9","author":"Padmanabhan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuint.2021.105070_bib51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuint.2021.105070_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1083\/jcb.135.1.153","article-title":"Rab8 promotes polarized membrane transport through reorganization of actin and microtubules in fibroblasts","volume":"135","author":"Peranen","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuint.2021.105070_bib53","doi-asserted-by":"crossref","first-page":"31391","DOI":"10.1038\/srep31391","article-title":"Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker","volume":"6","author":"Perera","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2021.105070_bib54","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuint.2021.105070_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.201798099","article-title":"Rab29 activation of the Parkinson's disease-associated LRRK2 kinase","volume":"37","author":"Purlyte","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2021.105070_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2014.00054","article-title":"LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status","volume":"7","author":"Reynolds","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2021.105070_bib57","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1074\/jbc.RA118.005008","article-title":"The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A","volume":"294","author":"Rivero-Rios","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2021.105070_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","article-title":"Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-kappaB p50 signaling in cultured microglia cells","volume":"12","author":"Russo","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2021.105070_bib59","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1093\/hmg\/ddu138","article-title":"Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagy","volume":"23","author":"Schapansky","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105070_bib60","doi-asserted-by":"crossref","first-page":"164ra161","DOI":"10.1126\/scitranslmed.3004485","article-title":"Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations","volume":"4","author":"Sheng","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2021.105070_bib61","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31012","article-title":"Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis","volume":"6","author":"Steger","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.neuint.2021.105070_bib62","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neuint.2021.105070_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198943","article-title":"Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages","volume":"13","author":"Taciak","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2021.105070_bib64","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1476-5381.2009.00297.x","article-title":"Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model","volume":"157","author":"Takashima","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2021.105070_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021519","article-title":"Regulation of LRRK2 expression points to a functional role in human monocyte maturation","volume":"6","author":"Thevenet","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2021.105070_bib66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2021.105070_bib67","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1111\/febs.13305","article-title":"Cellular processes associated with LRRK2 function and dysfunction","volume":"282","author":"Wallings","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.neuint.2021.105070_bib68","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1042\/BST20180463","article-title":"LRRK2 regulation of immune-pathways and inflammatory disease","volume":"47","author":"Wallings","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuint.2021.105070_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128906","article-title":"Leucine-rich repeat kinase 2 (Lrrk2) deficiency diminishes the development of experimental autoimmune uveitis (EAU) and the adaptive immune response","volume":"10","author":"Wandu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2021.105070_bib70","doi-asserted-by":"crossref","first-page":"16842","DOI":"10.1073\/pnas.0507360102","article-title":"Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity","volume":"102","author":"West","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105070_bib71","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2021.105070_bib72","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000289232","article-title":"Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation","volume":"7","author":"Wider","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.neuint.2021.105070_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000902","article-title":"GTPase activity plays a key role in the pathobiology of LRRK2","volume":"6","author":"Xiong","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuint.2021.105070_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","article-title":"Emerging views of mitophagy in immunity and autoimmune diseases","volume":"16","author":"Xu","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.neuint.2021.105070_bib75","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","article-title":"Genomewide association study of leprosy","volume":"361","author":"Zhang","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2021.105070_bib76","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018621001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018621001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:56:28Z","timestamp":1759312588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018621001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":76,"alternative-id":["S0197018621001169"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2021.105070","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abrogation of LRRK2 dependent Rab10 phosphorylation with TLR4 activation and alterations in evoked cytokine release in immune cells","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2021.105070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105070"}}